EP Patent

EP1530965A1 — Controlled release delivery system of sexual hormones for nasal application

Assigned to m&p Patent AG · Expires 2005-05-18 · 21y expired

What this patent protects

This invention relates to a pemasally administrable preparation for the controlled release of sexual hormones to the systemic circulation, in particular to a formulation which enables its active ingredient to be absorbed in a sustained manner providing a better bioavailability at…

USPTO Abstract

This invention relates to a pemasally administrable preparation for the controlled release of sexual hormones to the systemic circulation, in particular to a formulation which enables its active ingredient to be absorbed in a sustained manner providing a better bioavailability at very low doses and longer duration of action.

Drugs covered by this patent

Patent Metadata

Patent number
EP1530965A1
Jurisdiction
EP
Classification
—
Expires
2005-05-18
Drug substance claim
No
Drug product claim
No
Assignee
m&p Patent AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.